EFSCE
LXRX icon

Enterprise Financial Services Corp (EFSC)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-142
Closed -$2K – 998
2017
Q1 		$2K Hold
142
– – ﹤0.01% 940
2016
Q4 		$2K Hold
142
– – ﹤0.01% 926
2016
Q3 		$3K Hold
142
– – ﹤0.01% 816
2016
Q2 		$2K Hold
142
– – ﹤0.01% 851
2016
Q1 		$2K Buy
+142
New +$1.49K ﹤0.01% 871

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.41% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s LXRX Position: Q2 2017 in Review

Enterprise Financial Services Corp (EFSC) sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2017, closing a stake of 142 shares — an estimated $2K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in LXRX in Q1 2016 and held it in 5 quarters. The position peaked at $3K in Q3 2016. 136 funds tracked by Wall St. Rank hold LXRX as of Q2 2017.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Lexicon Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 142 Lexicon Pharmaceuticals shares in Q2 2017, an estimated $2K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Lexicon Pharmaceuticals in Q1 2016 and held it in 5 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Lexicon Pharmaceuticals position peaked at $3K in Q3 2016.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2017.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2017, filed 28 Jul 2017.